Clinical and Research Lab Solutions

Lab Innovations Clinical and Research Lab Solutions

2024-07-04 Source: Press release Thermo Fisher Scientific 2 min Reading Time

Related Vendors

Thermo Fisher Scientific offers advanced tools and technologies that enhance flexibility and productivity for diagnostics development and support advanced allergy and autoimmune testing and drug monitoring.

Thermo Fisher Scientific has introduced innovative diagnostic technologies, assays and a complement of solutions for researchers developing new diagnostics. The workflow innovations give clinical laboratories and researchers greater flexibility and assurance as they respond to new and existing diagnostic challenges, shares the company.

By minimizing hands-on time, reducing time-to-results, and improving analytical performance, the firm is enabling the science that shapes the future of diagnostics, as it all works towards improving patient outcomes, adds the company.

The Applied Biosystems Taqman-Sars-Cov-2 Mutation Panel enables labs to build their own custom panel from a menu of verified real-time PCR assays. This meets the evolving needs of customers and public health agencies seeking to rapidly identify and survey current mutations as well as emerging variants.

To support labs as they move beyond Covid testing, Thermo Fisher is evolving its respiratory testing menu and improving automation to accelerate research. The Applied Biosystems Taqpath Covid-19, Flu A, Flu B Combo Kit helps labs expand their existing Covid-19 testing menu for respiratory samples while maintaining workflow simplicity and without increasing operational costs.

The Thermo Scientific Kingfisher Specitrax Sample Transfer System provides researchers in infectious diseases and genetics with an automated sample-handling system, including new features, such as an automated decapper, that relieve the sample processing bottleneck for increased throughput, opines the firm.

A new interface with the Inpeco’s Flexlab Total Laboratory Automation system (TLA), enables primary tubes on the Inpeco LAS to be transported directly to the Thermo Scientific Cascadion SM Clinical Analyzer for automated loading, pre-treatment and analysis. According to the company, this first-of-its-kind integration enables fully automated, gold-standard LC-MS/MS technology to improve clinical lab productivity.

The Thermo Scientific DRI Fentanyl II Drugs of Abuse Assay is available on medium to high-throughput instruments, including the Indiko Plus and Mindray BS-480, Mindray BA-800M. Labs of any size can now accurately test for multiple drugs of abuse at high volume using fully automated analyzers. Thermo Fisher’s broad and complementary offering of screening to confirmatory solutions also includes the Thermo Scientific Tox Explorer Collection, an all-in-one LC-MS/MS solution for toxicology.

The Thermo Scientific Elia RNA Pol III and Elia Rib-P tests have received U.S. FDA clearance for aiding in the diagnosis of Systemic Sclerosis and Systemic Lupus Erythematosus. These tests are part of a broader Elia portfolio of connective tissue disease tests that help provide a clearer clinical picture for patients.

(ID:50085983)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

Business E-mail

Please enter a valid mailadress.

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Date: 08.12.2025

Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.

Consent to the use of data for promotional purposes

I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here

Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.

Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.

In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.

Right of revocation

I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.